documents: FDA-2010-N-0621-0537

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2010-N-0621-0537 FDA FDA-2010-N-0621 Proposal to Withdraw Approval for the Breast Cancer Indication for Bevacizumab (Avastin) Public Hearing, June 28, 2011 - Transcript Other Transcript(s) 2011-11-03T04:00:00Z 2011 11 2011-11-03T04:00:00Z   2011-11-03T20:49:56Z   0 0 0900006480f65986

Links from other tables